Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has approved Watson Laboratories' Vestura (3 mg drospirenone and 0.02 mg ethinyl estradiol) abbreviated new drug application (ANDA).
Subscribe to our email newsletter
Watson’s Vestura is generic equivalent to Bayer’s Yaz oral contraceptive product.
Watson’s Vestura is an oral contraceptive used to prevent pregnancy and treat moderate acne in women.
The company claims that it is currently involved in patent litigation with Bayer regarding about its Vestura.